News 
Market Data 
Discover
In Florida overlooking the Intercoastal Waterway..
10 bagger
In Florida overlooking the Intercoastal Waterway..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In Florida overlooking the Intercoastal Waterway..
KLYG.. $0.105.. Nice buying going on today...
.www.mddionline.com/files/image/mddi/APART/Kelyniam.png[/chart]
Kelyniam CEO Tennyson Anthony holds up a model skull with the company's cranial implant
The established names in the world of custom cranial and facial implants are the likes of Biomet, Stryker and Synthes.
However, there are small, boutique firms as well that compete with the big guys for the surgeon's mindshare. One such small manufacturer with roots in aerospace mechanical engineering and rapid prototyping wants to make a big play in 2015 by taking a large chunk of the revenue pie.
Kelyniam, based in Canton, Connecticut, believes it can do that because of a combination of rapid turnaround times and ease of implant placement. The company has been selling its custom implants made of polyether ether ketone (PEEK) OPTIMA, a colorless organic thermoplastic polymer that is transparent to X-rays, since January, 2012 after obtaining approval from the FDA in April, 2011.
That gap was meant to ensure that Kelyniam could create a scalable product development and manufacturing process, says Tennyson Anthony, president and CEO of the company in a recent phone interview.
“We are very confident that we can handle a significant volume without a hitch” or increase in turnaround times, Anthony declares.
Since 2012, roughly 400 procedures have involved Kelyniam’s implants. The company has market clearances in the U.S. and the Middle East, and the company is working to obtain regulatory clearances in Canada and Australia.
The goal is to have significant growth in 2015 and gain a foothold in the facial implant market as well, where most implants are typically off-the-shelf products.
So what is Kelyniam’s turnaround time?
From the time that the company receives a CT scan to when the implant is available for surgery can take as little as 24 hours.
Kelyniam executives underscore that the rapid turnaround time is a competitive advantage. Other implant makers take several days if not weeks to produce their implants.
“I think one of the most interesting things that I have learned in the short time that I have been here, is this less than 24-hour turnaround,” says John Mulvihill, vice president of sales, who joined Kelyniam in November as part of an acquisition. “That is unheard of not only in this market but in many others almost to the point that we have a number of our competition that calls us and orders the Kelyniam custom implant for their cases because their system hasn’t shown up yet.”
A plastic surgeon says it’s not that common for facial implants to be custom made. Usually off-the-shelf products work, but when they need to be custom made that takes some time.
“These custom implants generally require several weeks before being available. The facial plastic surgeon works with the company to create an appropriate implant,” says Houtan Chaboki, plastic surgeon, George Washington Medical Faculty Associates in Washington, D.C, in an email.
But cranial implants, sometimes can be made "on the spot" by head or neck surgeons, neurosurgeons or plastic surgeons using a“combination of titanium plates and/or hydroxyapetite or similar material,” he explains.
Kelyniam’s website offers three plans for custom cranial implants – an expedited plan whose turnaround time is 24 hours, a second plan by which the product is ready for the surgeon in 72 hours while a third plan makes the implant available in five or six days.
Another company – Kelyniam competitor Dallas-based MedCAD - that also makes implants using PEEK polymer can produce them in a few days.
“Is it humanly possible to create an implant within 24 hours? Yes, but it’s not necessary,” says Nancy Hairston, CEO of MedCAD.
She says that her company’s products are rarely used in emergency trauma scenarios because typically you have to wait for the swelling to go down.
“To be honest, if they need it in 24 hours that means somebody hasn’t been organized and they are rushing to bring the patient in,” Hairston declares.
For Kelyniam, the market is split 50-50 into trauma cases and implants required as a result of diseases such as tumor resections, Anthony explains.
“One of the things that we feel sets us apart from our competition is that we are having great success in working with the surgeons and designing an implant even before the resection so that it can be done in one surgery, where the surgeon goes in and takes the tumor out and then have the implant right there to put in,” he says.
One of the company’s products is an implant with tabs already in place.
“It’s an actual extension of the PEEK implant and surgeons don’t need to get a separate plate during surgery, so they can just place the implant on and use the screws that are available there,” explains Mulvihill. “So this really saves a lot of time and money.”
And that becomes important at a time when hospitals are making purchasing decisions with a laser-like focus on cost containment.
“We are very conscious of where the healthcare field is going and everybody is looking for better value,” Anthony says. “So we come in with these tabs and we eliminate the need for plating that can save them upwards of $2,000 for a particular procedure just in plates and screws.”
Kelyniam's outside spokesman noted that the 24-hour turnaround time also helps to free up hospital resources because it means patients are spending less time in the hospital waiting for the implant depending on the type of case.
custom cranial implant, skull implant, trauma
Digital Image of Four-Piece Implant
Recently, the company helped create an implant for a U.S. patient that was particularly challenging. The patient had a gunshot wound, and from the CT scans, it was fairly obvious that there had been a previous surgery to secure broken bone, says Merwin Schaefer, Kelyniam’s chief design engineer.
“The part was created to mimic normal functioning of a healthy bone while reducing surgery and patient recovery times,” Schaefer says.
In fact, the final implant was a puzzle of four different pieces.
“The pieces were all slipped through a small incision and assembled once inside, which greatly reduced scarring and swelling and provided for a much better structural and aesthetic outcome,” Schaefer says.
Schaefer and company executives declined to say where the surgery was done because they are not at liberty to disclose details.
Already some physicians are noticing the Kelyniam difference, Tennyson says.
“We have had a doctor tell us that he truly believes that we saved a couple of his patients' lives because they came in and they were diagnosed with a tumor and they needed radiation treatment right away and because we were able to turn around the implant [quickly] that patient could receive the treatment within 48 hours,” he says.
Executives are hoping that such experiences will have a big impact on the company’s financial fortunes in 2015. The hope is also that a recent acquisition which brings the ability to bring to market neurostimulation products will boost financial results.
In the third quarter, Kelyniam had sales of $455,401 with a loss of $72,302. Kelyniam went public in 2008 and its stock is available over the counter.
Meanwhile, as it competes with companies like MedCAD, Kelyniam will also have to contend with the likes of Oxford Performance Materials, which has won FDA approval for its 3-D printed cranial and facial implants.
-- By Arundhati Parmar, Senior Editor, MD+DI
arundhati.parmar@ubm.com
===========================================================
KLYG.. $0.073 I spoke to the New PR guy who was actually aboard when KLYG traded above a Buck and he said that the tech and expertise was the reason for them buying another company.. I don't remember the 8K saying anything about sales.. I've followed KLYG for over 4 years now and they have rarely done anything to surprise me.. It is a small company and sales can vary a great deal on a few difference in the number of products being sold..
If you search Hank's Trading over the years you will find much Info not else where kept.. I believe that thier Implant's are finally gaining a grip on the market and that is thier reason to hire a PR firm.. Give him a call and he will cheer you up on any bad day in the market.. BTW I able to add 90,000 @0.07 Just before Xmas.. I think after the end of first Qtr. we could see $0.15 or higher.. Stockholders equity increased another 8% during the past qtr..
KLYG..$0.073
Statement of Income
For the 2nd and 3rd Quarter Ended September 30, 2014
KELYNIAM GLOBAL, INC.
June 30, 2014,, September 30, 2014,, Year to Date
Sales $436,865 $455,401 $1,432,552
Cost of Sales 222,138 172,674 665,310
Gross Profit 214,727 282,727 767,242
General and administrative expenses 221,070 210,427 649,445
Income from Operations (6,343) 72,300 117,797
Other Income
Interest income 2 2 8
Net Income (6,341) 72,302 117,805
www.kelyniam.com
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
KELYNIAM GLOBAL, INC.
Internally produced by Kelyniam - these financials have not been reviewed, audited, or compiled.
BALANCE SHEET
June 30, 2014
September 30, 2014
ASSETS
CURRENT ASSETS
Cash $63,599 $75,138
Accounts receivable 212,235 286,855
Inventory 54,576 16,632
Prepaid rent 3,752
Investment securities available for sale 160,777 131,455
Total current assets $491,187 $513,832
CAPITAL ASSETS
Manufacturing Equipment 359,582 359,582
Computer Equipment 24,982 24,982
Furniture and Fixtures 8,043 8,043
Leasehold Improvments 189,455 189,455
582,062 582,062
Less accumulated depreciation (322,483) (335,735)
Total capital assests 259,579 246,327
OTHER ASSETS
License, net of accumulated amortization of $9,930 35,139
License, net of accumulated amortization of $11,458 34,375
Security Deposit 8,000 8,000
Deferred income tax asset 650,318 650,318
Total other assets 693,457 692,693
TOTAL ASSETS $1,444,223 $1,452,852
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Notes payable $78,125 $63,750
Line of Credit - Bank 165,623 165,623
Credit cards payable 987
Commissions payable 47,245 35,150
Accrued expenses 64,293 74,630
Accrued interest 9,803 6,291
Current portion of capital leases 9,282 30,674
Current portion of long-term debt 30,238 26,880
Total current liabilities $405,596 $402,998
LONG-TERM DEBT
Long-term debt, less current portion 229,464 222,809
Capital lease obligations, less current portion 51,345 25,465
Total long-term debt 280,809 248,274
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
KLYG..$0.09.. Table Pounder.. It looks like we are on our way to becoming either a great stock or takeover.. hank
Custom Cranial Implant Company Aims For Big Push In 2015
Posted in Implantable Devices by Arundhati Parmar on December 11, 2014
A Connecticut company wants to take more market share in the custom cranial and facial implant world.
Kelyniam CEO Tennyson Anthony holds up a model skull with the company's cranial implant
The established names in the world of custom cranial and facial implants are the likes of Biomet, Stryker and Synthes.
However, there are small, boutique firms as well that compete with the big guys for the surgeon's mindshare. One such small manufacturer with roots in aerospace mechanical engineering and rapid prototyping wants to make a big play in 2015 by taking a large chunk of the revenue pie.
Kelyniam, based in Canton, Connecticut, believes it can do that because of a combination of rapid turnaround times and ease of implant placement. The company has been selling its custom implants made of polyether ether ketone (PEEK) OPTIMA, a colorless organic thermoplastic polymer that is transparent to X-rays, since January, 2012 after obtaining approval from the FDA in April, 2011.
That gap was meant to ensure that Kelyniam could create a scalable product development and manufacturing process, says Tennyson Anthony, president and CEO of the company in a recent phone interview.
“We are very confident that we can handle a significant volume without a hitch” or increase in turnaround times, Anthony declares.
Since 2012, roughly 400 procedures have involved Kelyniam’s implants. The company has market clearances in the U.S. and the Middle East, and the company is working to obtain regulatory clearances in Canada and Australia.
The goal is to have significant growth in 2015 and gain a foothold in the facial implant market as well, where most implants are typically off-the-shelf products.
So what is Kelyniam’s turnaround time?
From the time that the company receives a CT scan to when the implant is available for surgery can take as little as 24 hours.
Kelyniam executives underscore that the rapid turnaround time is a competitive advantage. Other implant makers take several days if not weeks to produce their implants.
“I think one of the most interesting things that I have learned in the short time that I have been here, is this less than 24-hour turnaround,” says John Mulvihill, vice president of sales, who joined Kelyniam in November as part of an acquisition. “That is unheard of not only in this market but in many others almost to the point that we have a number of our competition that calls us and orders the Kelyniam custom implant for their cases because their system hasn’t shown up yet.”
A plastic surgeon says it’s not that common for facial implants to be custom made. Usually off-the-shelf products work, but when they need to be custom made that takes some time.
“These custom implants generally require several weeks before being available. The facial plastic surgeon works with the company to create an appropriate implant,” says Houtan Chaboki, plastic surgeon, George Washington Medical Faculty Associates in Washington, D.C, in an email.
But cranial implants, sometimes can be made "on the spot" by head or neck surgeons, neurosurgeons or plastic surgeons using a“combination of titanium plates and/or hydroxyapetite or similar material,” he explains.
Kelyniam’s website offers three plans for custom cranial implants – an expedited plan whose turnaround time is 24 hours, a second plan by which the product is ready for the surgeon in 72 hours while a third plan makes the implant available in five or six days.
Another company – Kelyniam competitor Dallas-based MedCAD - that also makes implants using PEEK polymer can produce them in a few days.
“Is it humanly possible to create an implant within 24 hours? Yes, but it’s not necessary,” says Nancy Hairston, CEO of MedCAD.
She says that her company’s products are rarely used in emergency trauma scenarios because typically you have to wait for the swelling to go down.
“To be honest, if they need it in 24 hours that means somebody hasn’t been organized and they are rushing to bring the patient in,” Hairston declares.
For Kelyniam, the market is split 50-50 into trauma cases and implants required as a result of diseases such as tumor resections, Anthony explains.
“One of the things that we feel sets us apart from our competition is that we are having great success in working with the surgeons and designing an implant even before the resection so that it can be done in one surgery, where the surgeon goes in and takes the tumor out and then have the implant right there to put in,” he says.
One of the company’s products is an implant with tabs already in place.
“It’s an actual extension of the PEEK implant and surgeons don’t need to get a separate plate during surgery, so they can just place the implant on and use the screws that are available there,” explains Mulvihill. “So this really saves a lot of time and money.”
And that becomes important at a time when hospitals are making purchasing decisions with a laser-like focus on cost containment.
“We are very conscious of where the healthcare field is going and everybody is looking for better value,” Anthony says. “So we come in with these tabs and we eliminate the need for plating that can save them upwards of $2,000 for a particular procedure just in plates and screws.”
Kelyniam's outside spokesman noted that the 24-hour turnaround time also helps to free up hospital resources because it means patients are spending less time in the hospital waiting for the implant depending on the type of case.
custom cranial implant, skull implant, trauma
Digital Image of Four-Piece Implant
Recently, the company helped create an implant for a U.S. patient that was particularly challenging. The patient had a gunshot wound, and from the CT scans, it was fairly obvious that there had been a previous surgery to secure broken bone, says Merwin Schaefer, Kelyniam’s chief design engineer.
“The part was created to mimic normal functioning of a healthy bone while reducing surgery and patient recovery times,” Schaefer says.
In fact, the final implant was a puzzle of four different pieces.
“The pieces were all slipped through a small incision and assembled once inside, which greatly reduced scarring and swelling and provided for a much better structural and aesthetic outcome,” Schaefer says.
Schaefer and company executives declined to say where the surgery was done because they are not at liberty to disclose details.
Already some physicians are noticing the Kelyniam difference, Tennyson says.
“We have had a doctor tell us that he truly believes that we saved a couple of his patients' lives because they came in and they were diagnosed with a tumor and they needed radiation treatment right away and because we were able to turn around the implant [quickly] that patient could receive the treatment within 48 hours,” he says.
Executives are hoping that such experiences will have a big impact on the company’s financial fortunes in 2015. The hope is also that a recent acquisition which brings the ability to bring to market neurostimulation products will boost financial results.
In the third quarter, Kelyniam had sales of $455,401 with a loss of $72,302. Kelyniam went public in 2008 and its stock is available over the counter.
Meanwhile, as it competes with companies like MedCAD, Kelyniam will also have to contend with the likes of Oxford Performance Materials, which has won FDA approval for its 3-D printed cranial and facial implants.
-- By Arundhati Parmar, Senior Editor, MD+DI
arundhati.parmar@ubm.com
===========================================================
KLYG.. $0.073 I spoke to the New PR guy who was actually aboard when KLYG traded above a Buck and he said that the tech and expertise was the reason for them buying another company.. I don't remember the 8K saying anything about sales.. I've followed KLYG for over 4 years now and they have rarely done anything to surprise me.. It is a small company and sales can vary a great deal on a few difference in the number of products being sold..
If you search Hank's Trading over the years you will find much Info not else where kept.. I believe that thier Implant's are finally gaining a grip on the market and that is thier reason to hire a PR firm.. Give him a call and he will cheer you up on any bad day in the market.. BTW I able to add 90,000 @0.07 Just before Xmas.. I think after the end of first Qtr. we could see $0.15 or higher.. Stockholders equity increased another 8% during the past qtr..
KLYG..$0.073
Statement of Income
For the 2nd and 3rd Quarter Ended September 30, 2014
KELYNIAM GLOBAL, INC.
June 30, 2014,, September 30, 2014,, Year to Date
Sales $436,865 $455,401 $1,432,552
Cost of Sales 222,138 172,674 665,310
Gross Profit 214,727 282,727 767,242
General and administrative expenses 221,070 210,427 649,445
Income from Operations (6,343) 72,300 117,797
Other Income
Interest income 2 2 8
Net Income (6,341) 72,302 117,805
www.kelyniam.com
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
KELYNIAM GLOBAL, INC.
Internally produced by Kelyniam - these financials have not been reviewed, audited, or compiled.
BALANCE SHEET
June 30, 2014
September 30, 2014
ASSETS
CURRENT ASSETS
Cash $63,599 $75,138
Accounts receivable 212,235 286,855
Inventory 54,576 16,632
Prepaid rent 3,752
Investment securities available for sale 160,777 131,455
Total current assets $491,187 $513,832
CAPITAL ASSETS
Manufacturing Equipment 359,582 359,582
Computer Equipment 24,982 24,982
Furniture and Fixtures 8,043 8,043
Leasehold Improvments 189,455 189,455
582,062 582,062
Less accumulated depreciation (322,483) (335,735)
Total capital assests 259,579 246,327
OTHER ASSETS
License, net of accumulated amortization of $9,930 35,139
License, net of accumulated amortization of $11,458 34,375
Security Deposit 8,000 8,000
Deferred income tax asset 650,318 650,318
Total other assets 693,457 692,693
TOTAL ASSETS $1,444,223 $1,452,852
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Notes payable $78,125 $63,750
Line of Credit - Bank 165,623 165,623
Credit cards payable 987
Commissions payable 47,245 35,150
Accrued expenses 64,293 74,630
Accrued interest 9,803 6,291
Current portion of capital leases 9,282 30,674
Current portion of long-term debt 30,238 26,880
Total current liabilities $405,596 $402,998
LONG-TERM DEBT
Long-term debt, less current portion 229,464 222,809
Capital lease obligations, less current portion 51,345 25,465
Total long-term debt 280,809 248,274
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852(/b)
KLYG..$0.09.. Table Pounder.. It looks like we are on our way to becoming either a great stock or takeover.. hank
Custom Cranial Implant Company Aims For Big Push In 2015
Posted in Implantable Devices by Arundhati Parmar on December 11, 2014
A Connecticut company wants to take more market share in the custom cranial and facial implant world.
Kelyniam CEO Tennyson Anthony holds up a model skull with the company's cranial implant
The established names in the world of custom cranial and facial implants are the likes of Biomet, Stryker and Synthes.
However, there are small, boutique firms as well that compete with the big guys for the surgeon's mindshare. One such small manufacturer with roots in aerospace mechanical engineering and rapid prototyping wants to make a big play in 2015 by taking a large chunk of the revenue pie.
Kelyniam, based in Canton, Connecticut, believes it can do that because of a combination of rapid turnaround times and ease of implant placement. The company has been selling its custom implants made of polyether ether ketone (PEEK) OPTIMA, a colorless organic thermoplastic polymer that is transparent to X-rays, since January, 2012 after obtaining approval from the FDA in April, 2011.
That gap was meant to ensure that Kelyniam could create a scalable product development and manufacturing process, says Tennyson Anthony, president and CEO of the company in a recent phone interview.
“We are very confident that we can handle a significant volume without a hitch” or increase in turnaround times, Anthony declares.
Since 2012, roughly 400 procedures have involved Kelyniam’s implants. The company has market clearances in the U.S. and the Middle East, and the company is working to obtain regulatory clearances in Canada and Australia.
The goal is to have significant growth in 2015 and gain a foothold in the facial implant market as well, where most implants are typically off-the-shelf products.
So what is Kelyniam’s turnaround time?
From the time that the company receives a CT scan to when the implant is available for surgery can take as little as 24 hours.
Kelyniam executives underscore that the rapid turnaround time is a competitive advantage. Other implant makers take several days if not weeks to produce their implants.
“I think one of the most interesting things that I have learned in the short time that I have been here, is this less than 24-hour turnaround,” says John Mulvihill, vice president of sales, who joined Kelyniam in November as part of an acquisition. “That is unheard of not only in this market but in many others almost to the point that we have a number of our competition that calls us and orders the Kelyniam custom implant for their cases because their system hasn’t shown up yet.”
A plastic surgeon says it’s not that common for facial implants to be custom made. Usually off-the-shelf products work, but when they need to be custom made that takes some time.
“These custom implants generally require several weeks before being available. The facial plastic surgeon works with the company to create an appropriate implant,” says Houtan Chaboki, plastic surgeon, George Washington Medical Faculty Associates in Washington, D.C, in an email.
But cranial implants, sometimes can be made "on the spot" by head or neck surgeons, neurosurgeons or plastic surgeons using a“combination of titanium plates and/or hydroxyapetite or similar material,” he explains.
Kelyniam’s website offers three plans for custom cranial implants – an expedited plan whose turnaround time is 24 hours, a second plan by which the product is ready for the surgeon in 72 hours while a third plan makes the implant available in five or six days.
Another company – Kelyniam competitor Dallas-based MedCAD - that also makes implants using PEEK polymer can produce them in a few days.
“Is it humanly possible to create an implant within 24 hours? Yes, but it’s not necessary,” says Nancy Hairston, CEO of MedCAD.
She says that her company’s products are rarely used in emergency trauma scenarios because typically you have to wait for the swelling to go down.
“To be honest, if they need it in 24 hours that means somebody hasn’t been organized and they are rushing to bring the patient in,” Hairston declares.
For Kelyniam, the market is split 50-50 into trauma cases and implants required as a result of diseases such as tumor resections, Anthony explains.
“One of the things that we feel sets us apart from our competition is that we are having great success in working with the surgeons and designing an implant even before the resection so that it can be done in one surgery, where the surgeon goes in and takes the tumor out and then have the implant right there to put in,” he says.
One of the company’s products is an implant with tabs already in place.
“It’s an actual extension of the PEEK implant and surgeons don’t need to get a separate plate during surgery, so they can just place the implant on and use the screws that are available there,” explains Mulvihill. “So this really saves a lot of time and money.”
And that becomes important at a time when hospitals are making purchasing decisions with a laser-like focus on cost containment.
“We are very conscious of where the healthcare field is going and everybody is looking for better value,” Anthony says. “So we come in with these tabs and we eliminate the need for plating that can save them upwards of $2,000 for a particular procedure just in plates and screws.”
Kelyniam's outside spokesman noted that the 24-hour turnaround time also helps to free up hospital resources because it means patients are spending less time in the hospital waiting for the implant depending on the type of case.
custom cranial implant, skull implant, trauma
Digital Image of Four-Piece Implant
Recently, the company helped create an implant for a U.S. patient that was particularly challenging. The patient had a gunshot wound, and from the CT scans, it was fairly obvious that there had been a previous surgery to secure broken bone, says Merwin Schaefer, Kelyniam’s chief design engineer.
“The part was created to mimic normal functioning of a healthy bone while reducing surgery and patient recovery times,” Schaefer says.
In fact, the final implant was a puzzle of four different pieces.
“The pieces were all slipped through a small incision and assembled once inside, which greatly reduced scarring and swelling and provided for a much better structural and aesthetic outcome,” Schaefer says.
Schaefer and company executives declined to say where the surgery was done because they are not at liberty to disclose details.
Already some physicians are noticing the Kelyniam difference, Tennyson says.
“We have had a doctor tell us that he truly believes that we saved a couple of his patients' lives because they came in and they were diagnosed with a tumor and they needed radiation treatment right away and because we were able to turn around the implant [quickly] that patient could receive the treatment within 48 hours,” he says.
Executives are hoping that such experiences will have a big impact on the company’s financial fortunes in 2015. The hope is also that a recent acquisition which brings the ability to bring to market neurostimulation products will boost financial results.
In the third quarter, Kelyniam had sales of $455,401 with a loss of $72,302. Kelyniam went public in 2008 and its stock is available over the counter.
Meanwhile, as it competes with companies like MedCAD, Kelyniam will also have to contend with the likes of Oxford Performance Materials, which has won FDA approval for its 3-D printed cranial and facial implants.
-- By Arundhati Parmar, Senior Editor, MD+DI
arundhati.parmar@ubm.com
===========================================================
KLYG.. $0.073 I spoke to the New PR guy who was actually aboard when KLYG traded above a Buck and he said that the tech and expertise was the reason for them buying another company.. I don't remember the 8K saying anything about sales.. I've followed KLYG for over 4 years now and they have rarely done anything to surprise me.. It is a small company and sales can vary a great deal on a few difference in the number of products being sold..
If you search Hank's Trading over the years you will find much Info not else where kept.. I believe that thier Implant's are finally gaining a grip on the market and that is thier reason to hire a PR firm.. Give him a call and he will cheer you up on any bad day in the market.. BTW I able to add 90,000 @0.07 Just before Xmas.. I think after the end of first Qtr. we could see $0.15 or higher.. Stockholders equity increased another 8% during the past qtr..
KLYG..$0.073
Statement of Income
For the 2nd and 3rd Quarter Ended September 30, 2014
KELYNIAM GLOBAL, INC.
June 30, 2014,, September 30, 2014,, Year to Date
Sales $436,865 $455,401 $1,432,552
Cost of Sales 222,138 172,674 665,310
Gross Profit 214,727 282,727 767,242
General and administrative expenses 221,070 210,427 649,445
Income from Operations (6,343) 72,300 117,797
Other Income
Interest income 2 2 8
Net Income (6,341) 72,302 117,805
www.kelyniam.com
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
KELYNIAM GLOBAL, INC.
Internally produced by Kelyniam - these financials have not been reviewed, audited, or compiled.
BALANCE SHEET
June 30, 2014
September 30, 2014
ASSETS
CURRENT ASSETS
Cash $63,599 $75,138
Accounts receivable 212,235 286,855
Inventory 54,576 16,632
Prepaid rent 3,752
Investment securities available for sale 160,777 131,455
Total current assets $491,187 $513,832
CAPITAL ASSETS
Manufacturing Equipment 359,582 359,582
Computer Equipment 24,982 24,982
Furniture and Fixtures 8,043 8,043
Leasehold Improvments 189,455 189,455
582,062 582,062
Less accumulated depreciation (322,483) (335,735)
Total capital assests 259,579 246,327
OTHER ASSETS
License, net of accumulated amortization of $9,930 35,139
License, net of accumulated amortization of $11,458 34,375
Security Deposit 8,000 8,000
Deferred income tax asset 650,318 650,318
Total other assets 693,457 692,693
TOTAL ASSETS $1,444,223 $1,452,852
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Notes payable $78,125 $63,750
Line of Credit - Bank 165,623 165,623
Credit cards payable 987
Commissions payable 47,245 35,150
Accrued expenses 64,293 74,630
Accrued interest 9,803 6,291
Current portion of capital leases 9,282 30,674
Current portion of long-term debt 30,238 26,880
Total current liabilities $405,596 $402,998
LONG-TERM DEBT
Long-term debt, less current portion 229,464 222,809
Capital lease obligations, less current portion 51,345 25,465
Total long-term debt 280,809 248,274
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
AI
